Moreover, the TFPI-2 methylation level has been found to be high and frequent in the peritumoral mucosa of cancer patients and aberrant methylation of TFPI-2 has been identified in CRC development, during transition from its precursor-adenoma to cancer [94]. This evidence concerns the gene TFPI2 and colorectal carcinoma.